NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Alembic Pharmaceuticals delivered a strong Q1 FY27 performance with consolidated revenue reaching INR 2,150 Cr. The growth was spearheaded by a 49% surge in the US Generics business and a 33% increase in the API segment, leading management to raise the overall annual growth guidance.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.